Systemic lupus erythematosus is a prototypic autoimmune disease characterized by
antibodies to DNA and other nuclear molecules. While these antibodies can form immune …

Broadly HIV-1–neutralizing antibodies (BnAbs) display one or more unusual traits, including
a long heavy chain complementarity-determining region 3 (HCDR3), polyreactivity, and …

Objective Vitamin D modulates the immune response and blocks induction of an interferon (IFN)
signature by systemic lupus erythematosus (SLE) sera. This study was undertaken to …

Objective Some sources urge caution when prescribing hydroxychloroquine ( HCQ ) to patients
with G6 PDH deficiency, presumably due to a risk of hemolytic anemia. There are limited …

Objective While increased disease activity is the best predictor of preterm birth in women
with systemic lupus erythematosus (SLE), even women with low disease activity are at …

Objective Medication nonadherence is more common in African Americans compared with
Caucasians. We examined the racial adherence gaps among patients with systemic lupus …

Background Depressive symptoms affect anywhere from 11% to 71% of patients with systemic
lupus erythematosus (SLE), which may be related to SLE disease activity, other clinical …

Objective We have developed a new conceptual model to characterise the signs and symptoms
of SLE: the Type 1 and 2 SLE Model. Within the original model, Type 1 SLE consists of …

Objective Systemic lupus erythematosus (SLE) flares are associated with increased damage
and decreased health-related quality of life. We hypothesized that there is discordance …

Objective The type 1 and type 2 systemic lupus erythematosus (SLE) categorization system
was recently proposed to validate the patients’ perspective of disease and to capture a more …